171 articles for regulatory affairs professionals in pharma, biotech and medical devices: career guidance, role profiles, hiring trends and policy explainers. Updated Oct 10, 2026.
5,000+ job seekers
joined our newsletter
Showing 1–8 of 8 articles
Regulatory CMC and clinical regulatory affairs mean different daily work and different long-term trajectories. How to think through the early-career choice.
What ICH guidelines actually are, the Q/S/E/M families regulatory affairs work runs on daily, and why harmonization still leaves room for regional expertise.
A practical look at how the regulatory affairs job itself changes moving from big pharma to a small biotech, from scope and speed to compensation and risk.
A complete response letter is not a rejection. Here's how regulatory affairs teams actually read it, build the response, and manage the resubmission.
How to evaluate a regulatory affairs offer from an early-stage biotech: equity math, cash runway, pipeline risk, title inflation, and the questions worth asking before you sign.
A practical guide to reading, scoping, and drafting a response to an FDA information request without triggering unnecessary delay or scope creep.
What transfers and what doesn't when a regulatory affairs professional moves into a new therapeutic area mid-career, and how to position the switch honestly.
How working regulatory affairs at a sponsor company differs from working at a CRO or regulatory consultancy, and how to decide which path fits you.
